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Abstract
A rapid and sensitive direct competitive fluorescence enzyme immunoassay (dc-FEIA) for 
ochratoxin A (OTA) based on a nanobody (Nb)-alkaline phosphatase (AP) fusion protein was 
developed. The VHH gene of Nb28 was subcloned into the expression vector pecan45 containing 
the AP double mutant gene. The Nb28-AP construct was transformed into E. coli 
BL21(DE3)plysS and soluble expression in bacteria was confirmed by SDS-PAGE and Western 
blot. Both the Nb properties and AP enzymatic activity were validated by colorimetric and 
fluorometric analysis. The 50% inhibitory concentration and the detection limit of the dc-FEIA 
were 0.13 ng/mL and 0.04 ng/mL, respectively, with a linear range of 0.06–0.43 ng/mL. This 
assay was compared with LC-MS/MS, and the results indicated the reliability of Nb-AP fusion 
protein-based dc-FEIA for monitoring OTA contamination in cereal.
Keywords
Nanobody; ochratoxin A; alkaline phosphatase; fusion protein; fluorescence enzyme immunoassay
Copyright © American Chemical Society.
*Corresponding Author Yang Xu, Dr. Prof.; Tel.: +86-791-88329479; Fax: +86-791-88333708; xuyang@ncu.edu.cn. 
Supporting Information Available
Additional information as noted in text. This material is available free of charge via the Internet at http://pubs.acs.org.
Author Contributions




Anal Chem. Author manuscript; available in PMC 2016 January 20.
Published in final edited form as:













Ochratoxin A (OTA) is a secondary metabolite primarily produced by Aspergillus and 
Pencillium species,1, 2 which can contaminate cereal and cereal products around the 
world3–6. Many researches have revealed the diverse toxicities of OTA, including 
teratogenic, mutagenic, carcinogenic, hepatotoxic, immunosuppressive, and nephrotoxic 
effects.7–9 In 1993, the International Agency for Research on Cancer (IARC) classified OTA 
in group 2B as a possible human carcinogen.10 To regulate the content of OTA in food 
products, maximum limits of OTA have been set in cereals and cereal products at 5 µg/kg 
and 3 µg/kg in the European Union (EU), respectively.11
In order to minimize the risks of OTA exposure to consumers, many studies have been 
performed to develop methods for detection of OTA in cereal and cereal products, including 
gas chromatography, high-performance liquid chromatography, and immunoassays.12–15 
The instrumental methods are sensitive and specific, but they are laborious, expensive, and 
time-consuming, which are not suitable for routine analysis of large numbers of samples. In 
contrast, immunoassays have a unique ability to routinely handle a large number of samples 
and do not require time-consuming procedures and sophisticated equipment. They also lend 
themselves to point of use formats for rapid feedback of analytical data.
Most of the previously reported immunoassays for OTA are based on a monoclonal antibody 
or a polyclonal antibody, and are carried out with primary or secondary antibodies which are 
chemically labeled with enzymes, such as horseradish peroxidase (HRP).16–18 However, it 
has been reported that the chemical conjugation of enzymes to antibodies may result in the 
unstable and randomly cross-linked molecules.19,20 With the rapid development of antibody 
engineering and molecular cloning techniques, construction of single chain fragment of 
variable antibody region (scFv)-alkaline phosphatase (AP) fusions is considered an 
attractive alternative for simple and rapid immunoassay analysis, which can avoid the 
chemical conjugation of enzymes to antibodies and the use of a second antibody. It has been 
confirmed that the bivalent nature of AP contributes to the increased binding affinity of 
scFv-AP fusions to target antigens while retaining enzymatic activity.21,22 Many studies on 
the detection of small molecular weight compounds using scFv-AP fusions have been 
reported, such as ractopamine23 and O,O-diethyl organophosphorus pesticides24. However, 
scFvs are often observed to have poor solubility and stability which require complicated 
genetic engineering to improve.25,26 As an alternative to conventional antibodies, variable 
domain of heavy chain antibodies (VHHs), also known as nanobodies (Nbs), that are derived 
from the variable region of heavy chain antibody existing in camelids and sharks,27 is more 
attractive than scFv. Compared to scFv, Nbs have a smaller molecular weight of 15 kDa, 
high solubility and high expression in microbial systems.28 Furthermore, it has been 
demonstrated that Nbs can maintain their functional binding affinity and specificity by 
refolding to their native structure after heat or chemical denaturation.29,30 It has been 
reported that the fusion of AP to Nbs can broaden the application of this powerful 
immunodiagnostic reagent, such as enhancing the binding affinity compared to unfused 
Nbs.31 Recently, a study on the AP activity of scFv-AP fusion showed that the fluorometric 
assay allowed for more sensitive detection than the chemiluminescence assay, revealing the 
potential of AP fusions in developing a highly sensitive fluorescence enzyme 
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immunoassay.32 Up till now, there are few reports on the application of Nb-AP fusions in 
detection of toxic small molecular weight compounds.28,31
In our previous work, we reported on the panning of binders specific for OTA from an 
immunized alpaca VHH-derived Nb library, and sixteen binders with four different amino 
acid sequences were selected.33 In the research described here, the binder VHH-28 which 
showed the highest sensitivity in a phage ELISA was used to construct the Nb-AP. The Nb 
gene of phage isolate VHH-28 was cloned into the expression vector pecan45 which 
contained the AP gene to produce the Nb28-AP fusion protein. After the characterization by 
SDS-PAGE and Western blotting, the purified fusion protein was used to develop a rapid, 




T4 DNA ligase and restriction enzyme Sfi I were purchased from New England Biolabs, Inc. 
(Beverly, MA, USA). PfuTurbo Cx Hotstart DNA Polymerase was from Agilent 
Technologies Inc. (Santa Clara, CA, USA). Standards (ochratoxin A, aflatoxin B1, 
zearalenone, deoxynivalenol), isopropyl-β-D-1-thiogalactopyranoside (IPTG), and p-
nitrophenyl phosphate (pNPP) substrate were from Sigma-Aldrich (St. Louis, MO, USA). 
Standard ochratoxin B was from Bioaustralis (Smithfield, NSW, AUS). AttoPhos AP 
fluorescent substrate system was purchased from Promega (Madison, WI, USA). Chemically 
competent cells of E. coli TOP10F′ strain and E. coli BL21(DE3)plysS strain, B-PER 
bacterial protein extraction reagent, HisPur Ni-NTA resin, NuPAGE 12% Bis-Tris gel, and 
SYPRO Ruby protein gel stain were purchased from Thermo Fisher Scientific Inc. 
(Waltham, MA, USA). Primers AP-F and AP-R (Table S-1 in Supporting Information [SI]) 
were purchased from Integrated DNA Technologies (Coralville, IA, USA). BCIP/NBT 
phosphatase substrate (1-component) was from KPL Inc. (Gaithersburg, MD, USA). The 
vector pecan45 containing an AP double mutant gene was a generous gift from Dr. Jinny L. 
Liu and Dr. Ellen R. Goldman (Naval Research Laboratory, Center for Bio/Molecular 
Science and Engineering, Washington, DC, USA).
Construction of the recombinant plasmid pecan45-Nb28-AP
The recombinant plasmid encoding the Nb-AP fusion protein pecan45-Nb28-AP was 
constructed as shown in Figure 1. Briefly, primers AP-F and AP-R were used to amplify the 
Nb gene and add two Sfi I restriction enzyme sites flanking the 5′ and 3′ termini of the VHH 
coding sequence from the plasmid pHEN1-VHH28. The VHH gene PCR products were 
purified with QIAquick PCR Purification Kit (Chatsworth, CA, USA) and digested with Sfi I 
restriction enzyme. The purified VHH fragment was then ligated into a similarly digested 
vector pecan45 containing the AP gene at a 3:1 molar ratio using T4 DNA Ligase, followed 
by transforming the ligation products into the chemically competent cells of the E. coli 
TOP10F′ strain by heat shock (42 °C, 90 s). The transformed bacteria were spread on Luria-
Bertani (LB)-agar plates containing 50 µg/mL carbenicillin and positive clones were picked 
for plasmid extraction and DNA sequencing.
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Expression and identification of Nb-AP fusion proteins
The recombinant plasmid was transformed into E. coli BL21(DE3)plysS cells, and the 
colony was cultured in LB medium with 50 µg/mL carbenicillin at 37 °C until the OD600 
reached approximately 0.6–1.0. The culture was then induced with 0.5 mM IPTG at 30 °C 
by shaking at 250 rpm overnight. The bacteria cells were collected by centrifugation at 5000 
× g for 10 min and the fusion protein was extracted by the B-PER method according to the 
manufacturer’s instruction. In brief, 4 mL of B-PER reagent containing DNase I and EDTA-
free protease inhibitors were added into 1 g of cell pellet. The cells were suspended by 
pipetting up and down, followed by incubation at room temperature for 10 min. Then the 
suspension was centrifuged at 15000 × g for 5 min to separate soluble Nb-AP fusion protein 
from the insoluble proteins. The presence of Nb-AP fusion protein was determined by both 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot 
with the single component BCIP/NBT phosphatase substrate.
Purification of the anti-OTA Nb-AP fusion protein
The extracted Nb-AP fusion protein which contains a 6×Histidine tag was filtered through a 
0.22 µm sterile filter (Millipore, USA), followed by loading onto a high-capacity nickel-
IMAC resin column for purification. After washing with six resin-bed volumes of wash 
buffer (10 mM PBS containing 25 mM imidazole, pH 7.4), the Nb-AP fusion protein was 
eluted with 6 mL of elution buffer (10 mM PBS containing 100 mM imidazole, pH 7.4). 
After dialyzing with PBS (10 mM, pH 7.4) at 4 °C for 48 h, the purified Nb-AP fusion 
protein was stored at −20 °C until use, and the purity of Nb-AP fusion protein was evaluated 
by SDS-PAGE15.
Measurement of the AP activity of the Nb-AP fusion protein
Colorimetric analysis—Serially diluted Nb-AP fusion protein (50 µL) was added into a 
96-well microplate, followed by adding 100 µL of AP buffer (pH 10.4) containing 3.8 µM, 
0.1 M glycine, 50 mM MgCl2 and 50 mM ZnCl2. The plate was mixed and incubated at 37 
°C for 30 min. The reaction was stopped with 50 µL/well of 4 M NaOH. The well 
absorbance at 405 nm was measured on a microtiter plate reader (Molecular Devices, 
Sunnyvale, CA).
Fluorometric analysis—The AttoPhos AP fluorescent substrate (pH 10) that contains 1 
µM 2´-(2-benzothiazoyl)-6´-hydroxybenzothiazole phosphate (BBTP), 2.4 M 
diethanolamine (DEA), 57 µM MgCl2, and 0.005% NaN3 (100 µL) was added into a black 
opaque 96-well microplate, in which a serial dilution of Nb-AP fusion protein (50 µL) had 
been placed. The plate was mixed, followed by incubation at room temperature for 15 min. 
Then the fluorescence was measured on a microtiter plate reader (Molecular Devices, 
Sunnyvale, CA), in which the fluorescence excitation spectrum (435 nm) was collected with 
an emission wavelength of 575 nm.
Fluorescence enzyme immunoassay for OTA based on Nb-AP fusion protein
For this assay, a black opaque 96-well microplate was incubated with 100 µL/well of 0.5 
µg/mL OTA-ovalbumin (OVA) conjugate33 in PBS (5 mM, pH 7.4) at 4 °C overnight. After 
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blocking with 3% (w/v) skimmed milk powder in PBS (300 µL/well) at 37 °C for 1 h, the 
plate was washed 3 times with PBST (PBS, pH 7.4, 10 mM, containing 0.05% Tween-20). 
Subsequently, 50 µL/well of Nb-AP fusion protein diluted in PBS was added and incubated 
with 50 µL/well of serial concentrations of OTA standards (0, 0.01, 0.025, 0.05, 0.1, 0.25, 
0.5, 1 ng/mL in 5% methanol-PBS) at 37 °C for 30 min. After five washings with PBST, the 
plate was incubated with 100 µL/well of the AttoPhos AP fluorescent substrate at room 
temperature for 15 min. The fluorescent signal was measured as described above and 
standard curves were established by plotting the value of F/F0 (%) against the OTA 
concentration, where F is the fluorescence intensity in the presence of OTA or OTA-related 
analytes and F0 is the fluorescence intensity in their absence.
Sample preparation for dc-FEIA
Rice, oats and barley samples used for the spiking and recovery study were collected from 
local markets in Davis, California. Naturally contaminated cereal samples were obtained 
from different markets and supermarkets in the US. Sample preparation and extraction were 
performed as described by Wang.18 Briefly, 5 g of finely ground sample were weighed and 
spiked with 1, 2.5, 5, and 10 µg/kg OTA. The spiked samples were mixed with 10 mL of 
50% methanol in water (v/v) and subjected to ultrasonic extraction for 20 min. The mixture 
was centrifuged (10000 × g) at 4 °C for 10 min, and the supernatant was diluted 1 in 9 with 
PBS for FEIA analysis.
LC-MS/MS analysis of OTA
Chromatographic analysis was performed using an Acquity UPLC™ system (Waters Corp., 
Milford, MA) equipped with a binary solvent pump, an autosampler and column heater. The 
separation was carried out on a UPLC BEH C18 column (1.7 µm, 2.1 × 100 mm, 1.7 µm 
particle size, Kinetex, Phenomenex). The temperature of the sample plate was kept at 4 °C 
and 10 µL samples were injected on the column. The temperature of the column heater was 
maintained at 40 °C. Aqueous phase A was deionized water containing 0.1% formic acid as 
a modifier. Organic phase B was methanol containing 0.1% formic acid as a modifier. 
Starting gradient conditions were 10% B at 0.25 mL/min flow rate. The following gradient 
program was used: 0–1 min 10% B; 1–5 min 100% B; 5–8 min 100% B; 8–8.5 min 90% B; 
8.5–10 min 90% B.
The Quattro Premier tandem mass spectrometer (Waters) was operated in positive 
electrospray (ESI) mode under the following conditions: 25 L/h cone gas flow, 750 L/h 
desolvation gas flow, 120 °C source temperature, 350 °C desolvation temperature and 3.00 
kV capillary voltage. Argon was used as a collision gas at 2.2×10−3 mbar and flows 0.16 
mL/min. Precursor and corresponding product ions for the multiple reaction monitoring 
(MRM) detection are shown in Table S-2. The data were acquired using Masslynx 4.1 
software with Instrument and data processing was performed using MassLynx 4.1 with 
TargetLynx.
The extraction procedure was performed as described by Soleimany.34 Briefly, a ground 
cereal sample (5 g) was mixed with 20 mL of solution 1 (acetonitrile/water/acetic acid, 
79:20:1) by shaking 1 h on an orbital shaker. The mixture was centrifuged at 10000 rpm for 
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10 min, and 0.5 mL of the supernatant was diluted with the same volume of solution 2 
(acetonitrile/water/acetic acid, 20:79:1), followed by passing through a 0.22 µm filter before 
LC-MS/MS analysis.
RESULTS AND DISCUSSION
Expression, purification and characterization of the Nb-AP fusion protein
The positive recombinant plasmid confirmed by colony PCR (Figure S-1 in SI) and DNA 
sequencing was transformed into E. coli BL21(DE3)plysS cells. One colony was picked and 
cultured in LB medium with carbenicillin at 37 °C until the OD600 reached 0.8. The 
expression of the Nb-AP fusion protein was induced by 0.5 mM IPTG at 30 °C for 12 h. The 
periplasmic protein was extracted by the B-PER method and characterized by SDS-PAGE 
(Figure 2A) and Western blot (Figure 2B). A band of approximately 65 kDa was detected 
from the induced cell culture while this band was absent in the non-induced cell culture. The 
Western blot results indicated that the Nb-AP fusion protein was present as a single 65 kDa 
band. No degradation products were shown and no endogenous AP was detected, indicating 
the stability of the Nb-AP fusion protein.
AP enzyme activity and anti-OTA reactivity of Nb-AP fusion protein
The AP enzyme activity of Nb-AP fusion protein was evaluated using colorimetric and 
fluorometric analysis, respectively. As shown in Figure 3A, signal intensity decreased as the 
amount of Nb-AP fusion protein decreased, and the lowest amount of Nb-AP fusion 
detected by fluorometric analysis was approximately 20 times lower than the Nb-AP 
detected by colorimetric analysis, indicating the higher sensitivity of fluorometric analysis. 
In order to evaluate the anti-OTA reactivity of Nb-AP fusion protein, one-step direct 
competitive ELISA was carried out. Briefly, 50 µL of serial concentrations of OTA 
standards (0, 0.1, 0.25, 0.5, 1, 2.5, 5, 10, 25 ng/mL in 5% methanol-PBS) were added into a 
96-well microplate that had been coated with 2 µg/mL of OTA-OVA conjugate, followed by 
addition of an equal volume of Nb-AP fusion protein (0.5 µg/mL in PBS) and was mixed. 
The plate was incubated at 37 °C for 30 min and washed five times with PBST. 
Subsequently, pNPP substrate (100 µL) was added and incubated at 37 °C for 30 min. The 
reaction was stopped by the addition of 4 M NaOH (50 µL), and the absorbance of wells at 
405 nm was measured. As shown in Figure 3B, a standard competitive inhibition curve 
using the Nb-AP fusion protein was established by plotting B/B0 (%) against logarithm of 
OTA concentrations with Origin version 8.5 (OriginLab Corp., Northampton, MA), where B 
is the absorbance at 405 nm in the presence of OTA or OTA-related analytes and B0 is the 
absorbance at 405 nm in their absence. It is obvious that the binding between the Nb-AP 
fusion protein and OTA-OVA conjugate can be inhibited by free OTA (Figure 3B), showing 
the good anti-OTA reactivity of Nb-AP fusion protein.
FEIA for OTA using Nb-AP fusion protein as the probe
The performance of the purified Nb-AP fusion protein was tested by direct competitive 
FEIA with two parameters of IC50 and the ratio of the maximum relative fluorescence unit 
(RFUmax) to IC50 (RFUmax/IC50). To monitor the low concentrations of OTA, a highly 
sensitive detection scheme is the required with optimization of the concentration of coating 
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antigen and antibody, ionic strength, pH value, and organic solvent. The working 
concentration of OTA-OVA conjugate (0.5 µg/mL) and Nb-AP fusion protein (0.02 µg/mL) 
were first determined by a checkerboard titration. Methanol is a commonly used solvent in 
OTA analysis, since OTA is a highly lipophilic analyte. It has been reported that the 
interaction between antigen and antibody can be influenced by methanol35, so we evaluated 
the effect of different concentrations of methanol on the assay (Figure 4A). Both the 
RLUmax and the IC50 increased as the concentration of methanol increased, indicating the 
methanol can influence the activity of Nb-AP fusion. The lowest IC50 and the highest 
RLUmax/IC50 was observed at 2.5% methanol-PBS, so the assay buffer containing a final 
concentration of 2.5% methanol was chosen for further optimization. It has been reported 
that both ionic strength and pH can influence immunoreactions.15 Different concentrations 
of PBS (5, 10, 25, 50 mM) were tested (Figure 4B), and it was obvious that the fluorescence 
intensity decreased greatly as the ionic strength increased. The lowest IC50 and the highest 
RFUmax/IC50 was observed at 5 mM PBS. The influence of the assay buffer with different 
pH on the FEIA was evaluated from 4.0 to 11.0 (Figure 4C). The FEIA was more likely to 
be influenced at low pH (≤ 6.0), since negligible RFUmax was detected at pH 4.0 and 5.0 (32 
and 31, respectively) and a high IC50 (4.3 ng/mL) was shown at pH 6.0, which may be due 
to the denaturation of Nb-AP fusion protein caused by protein protonation at low pH.36 The 
RFUmax decreased as the pH increased from 7.4 to 11.0, while the IC50 varied in a narrow 
range of 0.2–0.6 ng/mL, indicating the feasibility of this assay to be performed at a pH 
ranging from 7.4 to 11.0. Taking account of the IC50 and RFUmax/IC50, the best 
performance was obtained at pH 7.4. A direct competitive Nb-AP fusion protein-based 
FEIA standard curve was established using the optimal conditions (Figure 5). The standard 
curve exhibited a good limit of detection of 0.04 ng/mL and a linear correlation coefficient 
of 0.998. The assay has a linear range (IC20-IC80) of 0.06–0.43 ng/mL and an IC50 of 0.13 
ng/mL.
Cross reactivity
To determine the selectivity of the assay, cross-reactivity (CR) of the Nb-AP fusion protein 
with OTA analog (OTB) and some other mycotoxins (deoxynivalenol, zearalenone, 
aflatoxin B1) which are commonly detected in contaminated cereal samples was evaluated 
by dc-FEIA. The cross-reactivity was calculated as: CR (%) = [IC50 (OTA)/IC50 (tested 
analytes)] × 100. As shown in Table 1, negligible CR was observed with any analyte, 
showing the good selectivity of Nb-AP fusion protein in dc-FEIA for OTA. Interestingly, in 
our previous work, a low CR(%) of 3.5% was detected with OTB for phage clone VHH28 in 
VHH phage-based competitive real-time immuno-PCR.33 Since the AP has a larger size (50 
KDa) than Nb (15 KDa), it can be inferred that the steric hindrance between Nb and fused 
AP may partly contribute to no CR with OTB for Nb-AP fusion protein in dc-FEIA.
Matrix effect
Matrix effect is a very common challenge of immunoassay for food analysis, which can 
cause false positive or negative results, lower sensitivity and reduce the specificity of the 
assay.37 The matrix effect can be reduced in a number of ways, such as dilution of sample 
extract or removal of interferences by sample cleanup procedures using solid-phase 
extraction. Dilution is a common way to reduce the matrix effect, but it can cause lower 
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sensitivity with a high dilution. Three sample matrixes (rice, oats, barley) were selected to 
evaluate the matrix effect, and each sample was confirmed to be free of OTA contamination 
by LC-MS/MS (LOD = 0.01 ng/mL). Sample extracts were diluted 10, 20, and 40 times and 
were used to prepare serial concentrations of OTA standards containing 5% methanol for the 
dc-FEIA. As shown in Figure 6, no significant reduction of maximum fluorescent intensity 
was observed, and the sensitivity was not affected, indicating the Nb-AP fusion protein was 
resistant to matrix effects. Taking the dilution into account, the final sensitivity of the FEIA 
was 0.8 µg/kg, with a linear range of 1.2–8.6 µg/kg, which is suitable for monitoring OTA 
contamination under current regulatory limits for OTA (5µg/kg) in the EU. Higher 
sensitivity could be obtained by improved clean up methods or additional assay 
optimization.
Validation study
To evaluate the effectiveness of the assay for OTA analysis, the Nb-AP fusion protein-based 
FEIA was performed to detect OTA in the spiked cereal samples. Before the spiking and 
recovery study, all samples were confirmed to be free of OTA contamination by LC-
MS/MS. Cereal samples spiked with four different concentrations of OTA (1, 2.5, 5, 10 
µg/kg) were prepared for intra- and inter-assay precision analysis. As shown in Table 2, the 
average recoveries for intra-assay ranged from 72% to 121%, with the coefficient of 
variation ranging from 0.02 to 0.13. Meanwhile, the results for the inter-assay ranged from 
73% to 109% and 0.05 to 0.09, respectively. In addition, eight breakfaset cereal samples 
naturally contaminated OTA were analyzed. These samples were made from rice, oats, or 
barley, and previously tested for OTA by HPLC with fluorescence detection.3 In this work, 
samples were analyzed in a blind fashion with dc-FEIA and LC-MS/MS. As shown in Table 
3, results obtained from the two methods were in good agreement with each other. The 
content of OTA in two oats samples (1 and 4) were beyond the maximum limit for OTA in 
cereal (5 µg/kg). These results indicate the acceptable accuracy and precision of the 
developed Nb-AP fusion protein-based dc-FEIA for OTA detection in cereal samples.
CONCLUSIONS
Thus we have developed a sensitive and selective immunoassay for ochratoxin A in a cereal 
matrix. Since these assays can be performed in a parallel rather than sequential fashion, they 
complement chromatographic assays in being able to handle large numbers of samples over 
a short period of time. The immunoassays offer a second advantage in allowing 
development of portable methods that can be run where the samples are collected and the 
data needed. From a technological standpoint the work illustrates the value of nanobodies 
(Nb, VHH) in small molecule analysis. Nb offer the advantages of monoclonal technology 
while yielding binding agents that are far less expensive to develop and to produce. Nb are 
more thermally stable than classical antibodies and, as demonstrated here, they are easily 
modified by simple recombinant DNA technology. We have also demonstrated that the 
alkaline phosphatase fusion method is applicable to small molecule analysis. Not only does 
the fusion technology speed the assay procedure and reduce variability by removing a step, 
but the formation of the alkaline phosphatase dimer increases the avidity and thus the 
sensitivity of the procedure.
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Schematic diagram of the construction of the expression plasmid for the Nb-AP fusion 
protein.
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(A) SDS-PAGE and (B) Western blot analysis of expression of the Nb28-AP fusion protein. 
Blots were stained with SYPRO Ruby protein gel stain or incubated with BCIP/NBT 
phosphatase substrate. Lane M, PageRuler unstained protein ladder (A) and spectra 
multicolor broad range protein ladder (B); Lane 1, whole-cell extract under non-induced 
conditions; Lane 2, whole-cell extract under induced conditions; Lane 3, purified Nb28-AP 
fusion protein by high-capacity nickel-IMAC resin.
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(A) Dose-response curves for AP enzyme activity of the purified Nb28-AP fusion protein 
determined by colorimetric (▪) and fluorometric (•) analysis. Error bars represent the 
standard derivation (n = 3). (B) Competitive binding curve (▲) based on Nb28-AP fusion 
protein by colorimetric analysis. The mixture of Nb28-AP fusion protein and free OTA was 
added into the 96-well microtiter plate coated with OTA-OVA conjugate (2 µg/mL), and 
then the binding was detected by incubation with pNPP substrate. Error bars represent the 
standard derivation (n = 3).
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Effects of (A) methanol, (B) ionic strength, and (C) pH on the performance of dc-FEIA for 
OTA probed with Nb28-AP fusion protein. The vertical bars indicate the standard deviation 
(n = 3).
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Standard competitive binding curve of Nb28-AP fusion protein-based dc-FEIA for OTA 
under optimized paramaters. The curve shows the inhibition of the Nb28-AP fusion protein 
binding to OTA-OVA conjugate with increasing concentrations of OTA standard. The 
optimized concentration of coating antigen and purified fusion protein in the assay was 0.5 
µg/mL and 16 ng/mL, respectively. Each point was tested in triplicate.
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Assay standard curves of Nb28-AP fusion protein in 2.5% methanol-PBS, rice (A), oats (B) 
and barley (C) matrix. Each assay was performed in triplicate.
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Table 1
Cross reactivity of Nb-AP fusion protein with OTA structural analogues
Analytes Chemical structure Cross-reactivity (%)
ochratoxin B < 0.01
deoxynivalenol < 0.01
aflatoxin B1 < 0.01
zearalenone < 0.01
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Table 2











Intra-assay (n = 3)a
Rice 1 1.18 ± 0.02 118 2
2.5 2.35 ± 0.15 94 6
5 3.60 ± 0.10 72 3
10 9.90 ± 0.75 99 8
Oats 1 1.21 ± 0.06 121 5
2.5 2.13 ± 0.28 85 13
5 4.50 ± 0.48 90 11
10 7.30 ± 0.02 73 3
Barley 1 0.85 ± 0.09 85 11
2.5 2.45 ± 0.18 98 7
5 3.75 ± 0.23 77 6
10 9.10 ± 0.43 91 5
Inter-assay (n = 6)b
Rice 1 1.09 ± 0.06 109 6
2.5 2.28 ± 0.17 91 7
5 3.65 ± 0.31 73 9
10 9.78 ± 0.52 98 5
a
Each assay was carried out in three replicates on the same day.
b
The assays were carried out on six different days.
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Table 3
Analysis of OTA content in cereal samples
Sample
FEIA








1 1.64 ± 0.10 6 1.45 ± 0.18 12
2 1.15 ± 0.11 10 1.80 ± 0.17 9
3 1.14 ± 0.09 8 2.03 ± 0.09 4
Oats
1 5.77 ± 0.23 5 7.53 ± 0.11 2
2 1.27 ± 0.04 3 0.82 ± 0.10 12
3 1.56 ± 0.11 7 1.22 ± 0.04 3
4 11.2 ± 1.1 10 12.0 ± 0.3 3
Barley
1 1.17 ± 0.10 9 1.83 ± 0.14 8
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